Cipla USA, Inc. recalls Diclofenac Sodium Topical Gel
- Recalling company
- Cipla USA, Inc.
- Product
- Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio, TX 78215. NDC: 76282-103-39
- Reason
- Failed PH Specifications
- Classification
- Class III – not likely to cause adverse health consequences
- Recall date
- Dec 22, 2025
- Reported
- Jan 28, 2026
- Distribution
- Nationwide in the USA
- Status
- Ongoing
- Quantity
- 92,376 tubes
- Lot / codes
- Batch XHBG; Exp. 08/31/2027
- Company location
- Warren, NJ
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0291-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0291-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.